GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Vaccine Inc (SZSE:301207) » Definitions » Ending Cash Position

Hualan Biological Vaccine (SZSE:301207) Ending Cash Position : ¥490 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Hualan Biological Vaccine Ending Cash Position?

Hualan Biological Vaccine's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥490 Mil.

Hualan Biological Vaccine's quarterly Ending Cash Position increased from Sep. 2024 (¥531 Mil) to Dec. 2024 (¥623 Mil) but then declined from Dec. 2024 (¥623 Mil) to Mar. 2025 (¥490 Mil).

Hualan Biological Vaccine's annual Ending Cash Position increased from Dec. 2022 (¥600 Mil) to Dec. 2023 (¥641 Mil) but then declined from Dec. 2023 (¥641 Mil) to Dec. 2024 (¥623 Mil).

Hualan Biological Vaccine Ending Cash Position Historical Data

The historical data trend for Hualan Biological Vaccine's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Vaccine Ending Cash Position Chart

Hualan Biological Vaccine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 351.20 114.79 600.04 640.98 623.04

Hualan Biological Vaccine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 623.99 1,262.49 531.25 623.04 490.19

Hualan Biological Vaccine Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hualan Biological Vaccine's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=640.98+-17.945
=623

Hualan Biological Vaccine's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=623.035+-132.848
=490

Hualan Biological Vaccine Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hualan Biological Vaccine's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Vaccine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Vaccine Inc (SZSE:301207) » Definitions » Ending Cash Position
Comparable Companies
SHSE:688105 SZSE:000990 SHSE:688177 SHSE:688443 SHSE:600645 SHSE:605116 SHSE:688739 SHSE:688062 SZSE:300049 SHSE:688136 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 1, No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Website
http://www.hualanbacterin.com
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.
Executives
Lou Yuan Cheng Supervisors

Hualan Biological Vaccine Headlines

No Headlines